Mercado global de tratamento da epistaxe – Tendências do setor e previsão para 2028

Análise e insights de mercado: Mercado global de tratamento da epistaxe

Espera-se que o mercado de tratamento da epistaxe ganhe crescimento de mercado no período de previsão de 2021 a 2028. A Data Bridge Market Research analisa que o mercado está a crescer a um CAGR de 5,30% no período de previsão de investigação acima mencionado . Aumento da população de doentes que dependem de medicamentos anticoagulantes e aumento de casos de infeção, alergias, bufo, hipertensão , entre outros.

A crescente população de doentes com caracteres hemorrágicos herdados e os avanços tecnológicos também impulsionam o crescimento do mercado. Além disso, os vigorosos esforços de investigação e desenvolvimento e o aumento dos gastos em saúde funcionam como uma oportunidade para o crescimento do mercado. Mas, por vezes, os efeitos adversos relacionados com os medicamentos, o elevado custo dos dispositivos e as regulamentações rigorosas podem dificultar o mercado global de tratamento da epistaxe.

A epistaxe resulta em hemorragia nasal incerta de ambas as narinas. Com base no local de origem da hemorragia, a epistaxe é classificada em epistaxe anterior e posterior. A epistaxe (hemorragia nasal) pode ser controlada até certo ponto em casa, mas em condições graves tornou-se bastante difícil controlar tal condição que exige tratamento adequado e novos dispositivos. Foi comunicado que aproximadamente 60% da população mundial apresenta epistaxe uma vez durante a vida. Entre os dois tipos de epistaxe, o tipo anterior é mais comum em crianças e pode ser tratado em casa, enquanto a epistaxe posterior necessita de tratamento médico específico. A epistaxe pode ser tratada com a aplicação de vasoconstritores tópicos, cautério químico, eletrocautério, cateter de Foley entre outros.

De acordo com a publicação do NCBI, foi relatado que a epistaxe é altamente prevalente em todo o mundo e é responsável por 2,4 milhões de mortes nos EUA. Esta população de doentes afectada depende, portanto, de uma abordagem de tratamento eficaz e, por isso, espera-se que proporcione ao mercado um crescimento rentável.

This epistaxis treatment market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global Epistaxis Treatment Market Scope and Market Size

Epistaxis treatment market is segmented on the basis of type, treatment, route of administration, end-users and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of type, the epistaxis treatment market is segmented into anterior and posterior.
• On the basis of treatment, the epistaxis treatment market is segmented into topical vasoconstrictors, chemical cautery, electrocautery, foley catheter, and arterial ligation or embolization. The topical vasoconstrictors segment in further sub- segmented into stimulants, amphetamines, and antihistamines. Amphetamines is sub-segmented into ritalin, concerta (methylphenidate), adderall, ephedrine. Antihistamines is further sub-segmented into chlorphenamine, hydroxyzine and promethazine, cetirizine, fexofenadine and loratadine.  
• On the basis of route of administration, the epistaxis treatment market is segmented into oral, parenteral, topical others.
• On the basis of end-users, the epistaxis treatment market is segmented into clinics, hospitals, homecare, others.
• On the basis of distribution channel, the epistaxis treatment market has also been segmented into hospital pharmacy, retail pharmacy, online pharmacy, others. 

Epistaxis Treatment Market Country Level Analysis

Epistaxis treatment market is analysed and market size information is provided by country, type, treatment, route of administration, end-users and distribution channel as referenced above.

The countries covered in the epistaxis treatment market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.

On geographical estimation, North America accounts the largest market share due to rising blood disorders, growing incidence of nasal and paranasal sinus cancers in U.S and Canada. Europe accounts the second largest market share due to changing environmental conditions and increasing collaboration and partnership for development of novel therapies.  Asia-Pacific is expected to account for the largest market share over coming years for the epistaxis treatment market due to increasing demand of effective treatment approaches and increasing investment for boosting up the drug manufacturing facilities.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Epistaxis treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Epistaxis Treatment Market Share Analysis

Epistaxis treatment market competitive landscape provides details by competitor, details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to epistaxis treatment market.

Os principais players abrangidos no mercado de tratamento da epistaxe são a Novartis AG, Noramco, Mallinckrodt, Johnson & Johnson Health Care Systems Inc., Teva Pharmaceuticals USA, Inc., Camber Pharmaceuticals, Inc., Amneal Pharmaceuticals LLC, Lannett, Takeda Pharmaceutical Company Limited , Zydus Cadila, Par Pharmaceutical, Aurobindo Pharma USA, AdvaCare Pharma, Pfizer Inc., Angiplast, Sterimed Group, Cardinal Health, Elanor Surgicals, hitecmed, BF ASCHER & CO., INC., Bayer, Smith & Nephew entre outros players nacionais e globais . Os analistas DBMR compreendem os pontos fortes competitivos e fornecem análises competitivas para cada concorrente em separado.

SKU-60109